logo-loader
CSE:NAB PINK:NABIF

Nabis Holdings Inc.

Receive alerts
Market:
CSE
Market Cap:
$3.3 m
Price
0.03 CAD
Change
20.00%
52 weeks high
0.68
52 weeks low
0.02

VISION

To be a leading investor in a portfolio of vertically integrated multi-state operations across the United States with global ambitions - establish “Anchor Investment Portfolio” of high quality assets in a short period of time at the right price.

STRATEGY

Identify and Acquire majority interests in high quality cash-flowing U.S. cannabis assets and brands in Limited License States at a reasonable price. Implement Nabis’ standards, consistency and operational experience with a focus on Pharma Grade quality products for both the medicinal, wellness and rec markets.

STRONG MANAGEMENT

Industry leading operators are two of the co-founders of MPX Bioceutical, the largest public takeover in the U.S. Cannabis industry to date (MPX merger with iAnthus for $835M CAD) 

TARGETING TOP MANAGEMENT

Limited license states, high revenue growth, positive EBITDA, vertically integrated operators in limited license states with large addressable consumer populations.

SYNERGY THROUGH SCALE

Adding investment,  operational, and product expertise throughout corporate structure to drive EBITDA growth

FOCUSED M&A
INVESTMENT STRATEGY

HANDS ON APPROACH

Nabis Management’s hands-on approach will assist investee companies enhance their operational pedigree

STRATEGY

Investments through combination of Cash & Shares along with incentive bonuses

ALIGNMENT

Strong preference for sellers to take a significant portion of the consideration in the form of equity—want sellers to be aligned with existing shareholders

 

THE CRITERIA

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis’ value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSO’s (Multi State Operators) with strong Brand traction
  • Pharma grade Cultivation, Extraction, Dispensaries and other addressable operations

SHAY SHNET

CEO & DIRECTOR

Shay has over 20 years of business experience and was most recently a founding partner and Vice President of Operations at MPX Bioceutical Corporation. Shay spent the last 5 years of his career focused on the North American cannabis space and helped to build MPX’s portfolio of international cannabis assets. Shay is adept at sourcing unique opportunities that deal directly with the development, branding, importing, consumer packaging and distribution of a variety of product lines.

MARK KRYTIUK

PRESIDENT & CHAIRMAN OF THE BOARD 

Mark is a successful cannabis operator and was a founding partner of MPX. Mark has over 5 years of experience as the Vice President of Grow Operations for MPX overseeing the production of medical marijuana and pharma-grade products across North America.Mark has been directly involved in the rapid expansion and growth of nine facilities in three different countries, with budgets up to $30 million. In addition, Mark has over 10 years of experience consulting and working with customers to develop personal requirements for their indoor & outdoor cultivation processing space; including aiding in design, workflow and equipment, as well as supporting federal regulators and licensing bodies to ensure compliance.

BOARD OF DIRECTORS

EMMANUEL PAUL
CPA, B.E.
DIRECTOR

Emmanuel currently serves as the Co-Founder and CEO of IndusCann Research, a business focused on the research and commercialization of medical cannabis in India. Most recently, he was the founding partner of Spartan Wellness Corporation, a unique veteran-focused health care service provider that specialized in prescribing medical cannabis, as well as providing education and ongoing care. Spartan Wellness was sold to MPX Bioceutical Corporation in September 2018.  Mr. Paul additionally acts as special advisor to a multitude of European cannabis licence holders in Germany, Denmark, Italy and Switzerland providing strategic management and developing new international cannabis trade opportunities between North America, Europe and Asia. Over the last 15 years, he has consulted with a multitude of companies in the technology, real estate, manufacturing and medical cannabis industries. He is a Chartered Professional Accountant (CPA) licensed in Ontario and BC. He also holds a Master of Science in Electrical Engineering and Bachelor of Science in Electrical and Electronics Engineering.

DR. SAFIYA LYN
DIRECTOR

Safiya is the Assistant Medical Director of a prestigious hospital in Aventura, Florida, which is among the nation’s oldest, largest and most respected hospital. Safiya has roughly 8 years of
experience in emergency medicine, offering valuable insight into the unique requirements related to various patient concerns. Safiya is responsible for overseeing a 16-bed acute care emergency room, managing general operations, caring for critical ill patients and implementing new policies related so sepsis, stroke, STEMI and critical care. Safiya works closely with her community to inform and educate people on evolving medical practices through engaging lectures and community-centered outreach
programs.